ArticleKidney international reports2025

Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community.

Roberto Pecoits-Filho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.